Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055686
Filing Date
2024-05-08
Accepted
2024-05-08 16:15:52
Documents
66
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q olma-20240331.htm   iXBRL 10-Q 2130377
2 EX-10.1 olma-ex10_1.htm EX-10.1 27380
3 EX-31.1 olma-ex31_1.htm EX-31.1 14324
4 EX-31.2 olma-ex31_2.htm EX-31.2 14345
5 EX-32.1 olma-ex32_1.htm EX-32.1 11517
  Complete submission text file 0000950170-24-055686.txt   8154649

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT olma-20240331.xsd EX-101.SCH 1101279
69 EXTRACTED XBRL INSTANCE DOCUMENT olma-20240331_htm.xml XML 1452716
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39712 | Film No.: 24926311
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)